mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.1 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |